British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015
Authors
Keywords
-
Journal
HIV MEDICINE
Volume 17, Issue -, Pages s2-s104
Publisher
Wiley
Online
2016-08-29
DOI
10.1111/hiv.12426
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of the Timing of Initiation of Antiretroviral Therapy During Primary HIV-1 Infection on the Decay of Cell-Associated HIV-DNA
- (2015) Moussa Laanani et al. CLINICAL INFECTIOUS DISEASES
- Emerging concepts on the use of antiretroviral therapy in older adults living with HIV infection
- (2015) Alan Winston et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Advancing the HIV cure agenda
- (2015) John Thornhill et al. CURRENT OPINION IN INFECTIOUS DISEASES
- The pharmacokinetic profile of raltegravir-containing antiretroviral therapy in HIV-infected individuals over 60 years of age
- (2015) Jaime H. Vera et al. HIV CLINICAL TRIALS
- 96-week resistance analyses of the STaR study: rilpivirine/emtricitabine/tenofovir DF versus efavirenz/emtricitabine/tenofovir DF in antiretroviral-naive, HIV-1-infected subjects
- (2015) Danielle P. Porter et al. HIV CLINICAL TRIALS
- Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life
- (2015) A Bamford et al. HIV MEDICINE
- Brief Report
- (2015) Joel E. Gallant et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Influence of nevirapine administration on the pharmacokinetics of dolutegravir in patients infected with HIV-1
- (2015) Eric Dailly et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial
- (2015) José R Arribas et al. LANCET INFECTIOUS DISEASES
- Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial
- (2015) José A Perez-Molina et al. LANCET INFECTIOUS DISEASES
- Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Preserving HIV-specific T cell responses
- (2015) Bernard J.C. Macatangay et al. Current Opinion in HIV and AIDS
- How can we better identify early HIV infections?
- (2015) Nora E. Rosenberg et al. Current Opinion in HIV and AIDS
- How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs?
- (2015) Jintanat Ananworanich et al. Current Opinion in HIV and AIDS
- Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
- (2015) Amanda Mocroft et al. PLOS MEDICINE
- Influence of the Timing of Antiretroviral Therapy on the Potential for Normalization of Immune Status in Human Immunodeficiency Virus 1–Infected Individuals
- (2015) Jason F. Okulicz et al. JAMA Internal Medicine
- Week 144 Resistance Analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Atazanavir+Ritonavir+Emtricitabine/Tenofovir DF in Antiretroviral-Naïve Patients
- (2015) Rima Kulkarni et al. HIV CLINICAL TRIALS
- Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection
- (2015) Janaki Amin et al. PLoS One
- Relative contribution of HIV infection, demographics and body mass index to bone mineral density
- (2014) Aoife G. Cotter et al. AIDS
- Long-term virological outcome in children on antiretroviral therapy in the UK and Ireland
- (2014) Trinh Duong et al. AIDS
- Long-term exposure to tenofovir continuously decrease renal function in HIV-1-infected patients with low body weight
- (2014) Takeshi Nishijima et al. AIDS
- Adherence to antiretroviral therapy in adolescents living with HIV
- (2014) Sung-Hee Kim et al. AIDS
- Safety of efavirenz in the first trimester of pregnancy
- (2014) Nathan Ford et al. AIDS
- HIV infection and incidence of ischemic stroke
- (2014) Julia L. Marcus et al. AIDS
- Antiretrovirals and the kidney in current clinical practice
- (2014) Jean C. Yombi et al. AIDS
- Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy
- (2014) Margaret T. May et al. AIDS
- Rilpivirine Versus Efavirenz with Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naïve HIV-1–Infected Patients with HIV-1 RNA ≤100,000 Copies/mL: Week 96 Pooled ECHO/THRIVE Subanalysis
- (2014) Georg Behrens et al. AIDS PATIENT CARE AND STDS
- Long-Term Use of Protease Inhibitors Is Associated with Bone Mineral Density Loss
- (2014) Ei Kinai et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Association Between Efavirenz as Initial Therapy for HIV-1 Infection and Increased Risk for Suicidal Ideation or Attempted or Completed Suicide
- (2014) Katie R. Mollan et al. ANNALS OF INTERNAL MEDICINE
- Associations Between HIV Infection and Subclinical Coronary Atherosclerosis
- (2014) Wendy S. Post et al. ANNALS OF INTERNAL MEDICINE
- Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor–Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1
- (2014) Jeffrey L. Lennox et al. ANNALS OF INTERNAL MEDICINE
- Switching safely: pharmacokinetics, efficacy and safety of switching efavirenz to maraviroc twice-daily in patients on suppressive antiretroviral therapy
- (2014) Laura Waters et al. ANTIVIRAL THERAPY
- Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis
- (2014) Nienke Langebeek et al. BMC Medicine
- Increased Virological Failure in Naive HIV-1-Infected Patients Taking Lamivudine Compared With Emtricitabine in Combination With Tenofovir and Efavirenz or Nevirapine in the Dutch Nationwide ATHENA Cohort
- (2014) C. Rokx et al. CLINICAL INFECTIOUS DISEASES
- A Case of Cerebrospinal Fluid Viral Escape on a Dual Antiretroviral Regimen: Worth the Risk?
- (2014) Davide Mangioni et al. CLINICAL INFECTIOUS DISEASES
- Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort Study
- (2014) J. Schouten et al. CLINICAL INFECTIOUS DISEASES
- Lower Pill Burden and Once-Daily Antiretroviral Treatment Regimens for HIV Infection: A Meta-Analysis of Randomized Controlled Trials
- (2014) Jean B. Nachega et al. CLINICAL INFECTIOUS DISEASES
- Role of CNS Transporters in the Pharmacotherapy of HIV-1 Associated Neurological Disorders
- (2014) Tamima Ashraf et al. CURRENT PHARMACEUTICAL DESIGN
- Effects of Combination Antiretroviral Therapies on the Risk of Myocardial Infarction Among HIV Patients
- (2014) Emily S. Brouwer et al. EPIDEMIOLOGY
- Early HIV Treatment In The United States Prevented Nearly 13,500 Infections Per Year During 1996–2009
- (2014) Dana P. Goldman et al. HEALTH AFFAIRS
- Switching From Twice-Daily Raltegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine to Once-Daily Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Virologically Suppressed, HIV-1–Infected Subjects: 48 Weeks Data
- (2014) A. Mills et al. HIV CLINICAL TRIALS
- Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks
- (2014) M Bloch et al. HIV MEDICINE
- Protease inhibitors and avascular necrosis: A systematic review and meta-analysis
- (2014) Nitipong Permpalung et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Bone Mineral Density Over 96 Weeks in Adults Failing First-Line Therapy Randomized to Raltegravir/Lopinavir/Ritonavir Compared With Standard Second-Line Therapy
- (2014) Hila Haskelberg et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Effectiveness of Antiretroviral Therapy in Individuals Who for Economic Reasons Were Switched From a Once-Daily Single-Tablet Regimen to a Triple-Tablet Regimen
- (2014) Frederik N. Engsig et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- End-Stage Kidney Disease and Kidney Transplantation in HIV-Positive Patients
- (2014) Esther Gathogo et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Tenofovir Alafenamide Vs. Tenofovir Disoproxil Fumarate in Single Tablet Regimens for Initial HIV-1 Therapy
- (2014) Paul E. Sax et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Switching from tenofovir/emtricitabine and nevirapine to a tenofovir/emtricitabine/rilpivirine single-tablet regimen in virologically suppressed, HIV-1-infected subjects
- (2014) C. Allavena et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Incomplete Reversibility of Estimated Glomerular Filtration Rate Decline Following Tenofovir Disoproxil Fumarate Exposure
- (2014) Sophie Jose et al. JOURNAL OF INFECTIOUS DISEASES
- Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study
- (2014) A. Castagna et al. JOURNAL OF INFECTIOUS DISEASES
- PROSPECTIVE RANDOMIZED CLINICAL TRIAL OF THE EFFECTS OF THREE MODERN ANTIRETROVIRAL THERAPIES ON CAROTID INTIMA-MEDIA THICKNESS IN HIV-INFECTED INDIVIDUALS (AIDS CLINICAL TRIALS GROUP STUDY A5260S)
- (2014) James H. Stein et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
- (2014) Colette J Smith et al. LANCET
- Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial
- (2014) François Raffi et al. LANCET
- Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study
- (2014) Bonaventura Clotet et al. LANCET
- Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial
- (2014) Pedro Cahn et al. LANCET INFECTIOUS DISEASES
- Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week results of a randomised, open-label, phase 3b, non-inferiority trial
- (2014) Jose R Arribas et al. LANCET INFECTIOUS DISEASES
- Switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and tenofovir in virologically suppressed adults with HIV (STRATEGY-NNRTI): 48 week results of a randomised, open-label, phase 3b non-inferiority trial
- (2014) Anton Pozniak et al. LANCET INFECTIOUS DISEASES
- Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial
- (2014) Beatriz Grinsztejn et al. LANCET INFECTIOUS DISEASES
- Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline
- (2014) I. Grant et al. NEUROLOGY
- Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa
- (2014) Nicholas I. Paton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis
- (2014) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomised Study to Assess the Efficacy and Safety of Once-Daily Etravirine-Based Regimen as a Switching Strategy in HIV-Infected Patients Receiving a Protease Inhibitor–Containing Regimen. Etraswitch Study
- (2014) Patricia Echeverría et al. PLoS One
- Randomised Pharmacokinetic Trial of Rifabutin with Lopinavir/Ritonavir-Antiretroviral Therapy in Patients with HIV-Associated Tuberculosis in Vietnam
- (2014) Nguyen Thi Ngoc Lan et al. PLoS One
- Efficacy of Initial Antiretroviral Therapy for HIV-1 Infection in Adults: A Systematic Review and Meta-Analysis of 114 Studies with up to 144 Weeks' Follow-Up
- (2014) Frederick J. Lee et al. PLoS One
- Simplification to Abacavir/Lamivudine + Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial
- (2014) David A. Wohl et al. PLoS One
- The RADAR Study: Week 48 Safety and Efficacy of RAltegravir Combined with Boosted DARunavir Compared to Tenofovir/Emtricitabine Combined with Boosted Darunavir in Antiretroviral-Naive Patients. Impact on Bone Health
- (2014) Roger J. Bedimo et al. PLoS One
- Attitudes and beliefs towards early ART initiation in MSM with primary HIV infection
- (2014) Victoria Parsons et al. Journal of the International AIDS Society
- Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infection
- (2014) John Thornhill et al. Journal of the International AIDS Society
- Phase IIIb, open-label single-arm trial of darunavir/cobicistat (DRV/COBI): Week 48 subgroup analysis of HIV-1-infected treatment-nave adults
- (2014) Karen Tashima et al. Journal of the International AIDS Society
- Once-daily dolutegravir is superior to once-daily darunavir/ritonavir in treatment-naïve HIV-1-positive individuals: 96 week results from FLAMINGO
- (2014) Jean-Michel Molina et al. Journal of the International AIDS Society
- Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant
- (2014) Kimberly Scarsi et al. Journal of the International AIDS Society
- No evident association between efavirenz use and suicidality was identified from a disproportionality analysis using the FAERS database
- (2014) Andrew A Napoli et al. Journal of the International AIDS Society
- Lack of association between use of efavirenz and death from suicide: evidence from the D:A:D study
- (2014) Colette Smith et al. Journal of the International AIDS Society
- Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients
- (2014) D. Keene et al. BMJ-British Medical Journal
- HIV-1 DNA predicts disease progression and post-treatment virological control
- (2014) James P Williams et al. eLife
- Atazanavir is not associated with an increased risk of cardio or cerebrovascular disease events
- (2013) Antonella d’Arminio Monforte et al. AIDS
- Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants
- (2013) Frank J. Palella et al. AIDS
- Deteriorating renal function and clinical outcomes in HIV-positive persons
- (2013) Amanda Mocroft et al. AIDS
- Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons
- (2013) Lene Ryom et al. AIDS
- Common clinical conditions – age, low BMI, ritonavir use, mild renal impairment – affect tenofovir pharmacokinetics in a large cohort of HIV-infected women
- (2013) Sanjiv M. Baxi et al. AIDS
- Safety, Tolerability, and Efficacy of Raltegravir in a Diverse Cohort of HIV-Infected Patients: 48-Week Results from the REALMRK Study
- (2013) Kathleen E. Squires et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Influence of Alternative Thresholds for Initiating HIV Treatment on Quality-Adjusted Life Expectancy: A Decision Model
- (2013) R. Scott Braithwaite ANNALS OF INTERNAL MEDICINE
- Sex-Based Outcomes of Darunavir–Ritonavir Therapy
- (2013) Judith Currier ANNALS OF INTERNAL MEDICINE
- Atazanavir Plus Ritonavir or Efavirenz as Part of a 3-Drug Regimen for Initial Treatment of HIV-1
- (2013) Eric S. Daar ANNALS OF INTERNAL MEDICINE
- When to Initiate Combined Antiretroviral Therapy to Reduce Mortality and AIDS-Defining Illness in HIV-Infected Persons in Developed Countries
- (2013) ANNALS OF INTERNAL MEDICINE
- Use of glomerular filtration rate estimating equations for drug dosing in HIV-positive patients
- (2013) Aghogho A Okparavero et al. ANTIVIRAL THERAPY
- Impaired Lipoprotein Processing in HIV Patients on Antiretroviral Therapy
- (2013) Baiba K. Gillard et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Outcomes by Sex Following Treatment Initiation With Atazanavir Plus Ritonavir or Efavirenz With Abacavir/Lamivudine or Tenofovir/Emtricitabine
- (2013) K. Y. Smith et al. CLINICAL INFECTIOUS DISEASES
- Relationship Between Weight, Efavirenz Exposure, and Virologic Suppression in HIV-Infected Patients on Rifampin-Based Tuberculosis Treatment in the AIDS Clinical Trials Group A5221 STRIDE Study
- (2013) Anne F. Luetkemeyer et al. CLINICAL INFECTIOUS DISEASES
- Low Baseline CD4+ Count Is Associated With Greater Bone Mineral Density Loss After Antiretroviral Therapy Initiation
- (2013) P. M. Grant et al. CLINICAL INFECTIOUS DISEASES
- Randomized Trial of Central Nervous System–Targeted Antiretrovirals for HIV-Associated Neurocognitive Disorder
- (2013) Ronald J. Ellis et al. CLINICAL INFECTIOUS DISEASES
- Contribution of Genetic Background, Traditional Risk Factors, and HIV-Related Factors to Coronary Artery Disease Events in HIV-Positive Persons
- (2013) Margalida Rotger et al. CLINICAL INFECTIOUS DISEASES
- SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitabine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen
- (2013) R. Campo et al. CLINICAL INFECTIOUS DISEASES
- Comparison of Risk Factors and Outcomes in HIV Immune Complex Kidney Disease and HIV-Associated Nephropathy
- (2013) M. C. Foy et al. Clinical Journal of the American Society of Nephrology
- HIV Protease Inhibitors in Pregnancy
- (2013) Nisha Andany et al. DRUGS
- Rilpivirine Versus Efavirenz in HIV-1–Infected Subjects Receiving Emtricitabine/Tenofovir DF: Pooled 96-Week Data from ECHO and THRIVE Studies
- (2013) M.R. Nelson et al. HIV CLINICAL TRIALS
- Efficacy and Safety 48 Weeks after Switching from Efavirenz to Rilpivirine Using Emtricitabine/Tenofovir Disoproxil Fumarate–Based Single-Tablet Regimens
- (2013) Anthony M. Mills et al. HIV CLINICAL TRIALS
- A meta-analysis of the efficacy and safety of unboosted atazanavir compared with ritonavir-boosted protease inhibitor maintenance therapy in HIV-infected adults with established virological suppression after induction
- (2013) J Baril et al. HIV MEDICINE
- Week 96 analysis of rilpivirine or efavirenz in HIV-1-infected patients with baseline viral load ≤ 100 000 copies/mL in the pooled ECHO and THRIVE phase 3, randomized, double-blind trials
- (2013) J-M Molina et al. HIV MEDICINE
- Mortality in perinatally HIV-infected young people in England following transition to adult care: an HIV Young Persons Network (HYPNet) audit
- (2013) R Fish et al. HIV MEDICINE
- Kidney transplantation in HIV-positive adults: the UK experience
- (2013) Esther N Gathogo et al. INTERNATIONAL JOURNAL OF STD & AIDS
- Effects of Switching From Efavirenz to Raltegravir on Endothelial Function, Bone Mineral Metabolism, Inflammation, and Renal Function
- (2013) Samir K. Gupta et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- A Randomized Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate for Initial Treatment of HIV-1 Infection
- (2013) Andrew Zolopa et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- A Randomized, Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vs Ritonavir-Boosted Atazanavir Plus Coformulated Emtricitabine and Tenofovir DF for Initial Treatment of HIV-1 Infection
- (2013) Jürgen K. Rockstroh et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Durable Efficacy and Safety of Raltegravir Versus Efavirenz When Combined With Tenofovir/Emtricitabine in Treatment-Naive HIV-1–Infected Patients
- (2013) Jürgen K. Rockstroh et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Immunodeficiency and Risk of Myocardial Infarction Among HIV-Positive Individuals With Access to Care
- (2013) Michael J. Silverberg et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- A Randomized, Double-Blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Single-Tablet Regimen Efavirenz/Emtricitabine/Tenofovir DF for Initial Treatment of HIV-1 Infection
- (2013) David A. Wohl et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- A Randomized, Double-blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vs Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir DF for Initial Treatment of HIV-1 Infection
- (2013) Nathan Clumeck et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Neurocognitive Functioning in Antiretroviral Therapy–Naïve Youth With Behaviorally Acquired Human Immunodeficiency Virus
- (2013) Sharon L. Nichols et al. JOURNAL OF ADOLESCENT HEALTH
- HIV infection is strongly associated with hip fracture risk, independently of age, gender, and comorbidities: A population-based cohort study
- (2013) Robert Güerri-Fernandez et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Impact of Switching From Zidovudine to Tenofovir Disoproxil Fumarate on Bone Mineral Density and Markers of Bone Metabolism in Virologically Suppressed HIV-1 Infected Patients; A Substudy of the PREPARE Study
- (2013) Aoife G. Cotter et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Quantification of Viral Loads Lower than 50 Copies per Milliliter by Use of the Cobas AmpliPrep/Cobas TaqMan HIV-1 Test, Version 2.0, Can Predict the Likelihood of Subsequent Virological Rebound to >50 Copies per Milliliter
- (2013) M. Alvarez Estevez et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The emergence of drug resistant HIV variants at virological failure of HAART combinations containing efavirenz, tenofovir and lamivudine or emtricitabine within the UK Collaborative HIV Cohort
- (2013) Naomi Bulteel et al. JOURNAL OF INFECTION
- Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Studya
- (2013) L. Ryom et al. JOURNAL OF INFECTIOUS DISEASES
- Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe
- (2013) A. De Luca et al. JOURNAL OF INFECTIOUS DISEASES
- Cobicistat Versus Ritonavir as a Pharmacoenhancer of Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naive HIV Type 1–Infected Patients: Week 48 Results
- (2013) Joel E. Gallant et al. JOURNAL OF INFECTIOUS DISEASES
- Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study
- (2013) Pedro Cahn et al. LANCET
- Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs
- (2013) Christine Katlama et al. LANCET
- Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study
- (2013) Francois Raffi et al. LANCET
- Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial
- (2013) François Raffi et al. LANCET INFECTIOUS DISEASES
- Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy
- (2013) Tuan Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection
- (2013) Sharon L. Walmsley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Cardiovascular Disease from Antiretroviral Therapy for HIV: A Systematic Review
- (2013) Clay Bavinger et al. PLoS One
- Sensitive Assessment of the Virologic Outcomes of Stopping and Restarting Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy
- (2013) Anna Maria Geretti et al. PLoS One
- Understanding Patients’ Adherence-Related Beliefs about Medicines Prescribed for Long-Term Conditions: A Meta-Analytic Review of the Necessity-Concerns Framework
- (2013) Rob Horne et al. PLoS One
- Can antiretroviral therapy prevent HIV-associated cognitive disorders?
- (2013) Alan Winston et al. Current Opinion in HIV and AIDS
- Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis
- (2013) Ingrid T Katz et al. Journal of the International AIDS Society
- Getting to the Heart of HIV and Myocardial Infarction
- (2013) Patrick W. G. Mallon JAMA Internal Medicine
- HIV Infection and the Risk of Acute Myocardial Infarction
- (2013) Matthew S. Freiberg et al. JAMA Internal Medicine
- Health Literacy: Impact on the Health of HIV-Infected Individuals
- (2013) Andrew J. Wawrzyniak et al. Current HIV/AIDS Reports
- Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care
- (2012) Robert C. Kalayjian et al. AIDS
- Association of tenofovir exposure with kidney disease risk in HIV infection
- (2012) Rebecca Scherzer et al. AIDS
- Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents
- (2012) Roger Bedimo et al. AIDS
- Week 96 efficacy and safety of rilpivirine in treatment-naive, HIV-1 patients in two Phase III randomized trials
- (2012) Calvin J. Cohen et al. AIDS
- Meta-Analysis of Gender Differences in Efficacy Outcomes for HIV-Positive Subjects in Randomized Controlled Clinical Trials of Antiretroviral Therapy (2000–2008)
- (2012) Guoxing (Greg) Soon et al. AIDS PATIENT CARE AND STDS
- Metabolic Effects of Darunavir/Ritonavir Versus Atazanavir/Ritonavir in Treatment-Naive, HIV Type 1-Infected Subjects over 48 Weeks
- (2012) Judith A. Aberg et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Baseline Kidney Function as Predictor of Mortality and Kidney Disease Progression in HIV-Positive Patients
- (2012) Fowzia Ibrahim et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA)
- (2012) Charles F Gilks et al. ANTIVIRAL THERAPY
- Second line protease inhibitor (PI/r) based antiretroviral therapy (ART) after non-nucleoside reverse transcriptase inhibitor (NNRTI) failure: impact of nucleoside (NRTI) backbone
- (2012) Laura Waters et al. ANTIVIRAL THERAPY
- A randomized comparison of second-line lopinavir/ritonavir monotherapy vs. tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI-regimens: the HIV STAR study
- (2012) Torsak Bunupuradah et al. ANTIVIRAL THERAPY
- High Incidence of Renal Stones Among HIV-Infected Patients on Ritonavir-Boosted Atazanavir Than in Those Receiving Other Protease Inhibitor-Containing Antiretroviral Therapy
- (2012) Y. Hamada et al. CLINICAL INFECTIOUS DISEASES
- Complicated Atazanavir-Associated Cholelithiasis: A Report of 14 Cases
- (2012) S. Rakotondravelo et al. CLINICAL INFECTIOUS DISEASES
- Plasma HIV-1 RNA Detection Below 50 Copies/mL and Risk of Virologic Rebound in Patients Receiving Highly Active Antiretroviral Therapy
- (2012) T. Doyle et al. CLINICAL INFECTIOUS DISEASES
- HIV Replication and Immune Status Are Independent Predictors of the Risk of Myocardial Infarction in HIV-Infected Individuals
- (2012) Sylvie Lang et al. CLINICAL INFECTIOUS DISEASES
- A Nucleoside- and Ritonavir-Sparing Regimen Containing Atazanavir Plus Raltegravir in Antiretroviral Treatment-Naïve HIV-Infected Patients: SPARTAN Study Results
- (2012) Michael J. Kozal et al. HIV CLINICAL TRIALS
- The MONET trial: week 144 analysis of the efficacy of darunavir/ritonavir (DRV/r) monotherapy versus DRV/r plus two nucleoside reverse transcriptase inhibitors, for patients with viral load
- (2012) JR Arribas et al. HIV MEDICINE
- Patients accessing HIV treatment via sexual health services: what are the risks of the dual case-note system?
- (2012) K Seden et al. INTERNATIONAL JOURNAL OF STD & AIDS
- Episodes of HIV Viremia and the Risk of Non-AIDS Diseases in Patients on Suppressive Antiretroviral Therapy
- (2012) Shuangjie Zhang et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Sustained Efficacy and Safety of Raltegravir After 5 Years of Combination Antiretroviral Therapy as Initial Treatment of HIV-1 Infection
- (2012) Eduardo Gotuzzo et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Ultrasensitive Assessment of Residual Low-Level HIV Viremia in HAART-Treated Patients and Risk of Virological Failure
- (2012) Franco Maggiolo et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Effect of Cobicistat on Glomerular Filtration Rate in Subjects With Normal and Impaired Renal Function
- (2012) Polina German et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Comparison of Ischemic Stroke Incidence in HIV-Infected and Non–HIV-Infected Patients in a US Health Care System
- (2012) Felicia C. Chow et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Maraviroc Once-Daily Nucleoside Analog-Sparing Regimen in Treatment-Naive Patients
- (2012) Anthony Mills et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Safety, Tolerability, and Pharmacokinetics of the HIV Integrase Inhibitor Dolutegravir Given Twice Daily With Rifampin or Once Daily With Rifabutin
- (2012) Kelly E. Dooley et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatment efficacy in UGT1A1*28 polymorphism carriers
- (2012) L. Ferraris et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens
- (2012) A. G. Marcelin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Prevalence of Low Bone Mineral Density in Men and Women Infected With Human Immunodeficiency Virus 1 and a Proposal for Screening Strategy
- (2012) Murielle Mary-Krause et al. JOURNAL OF CLINICAL DENSITOMETRY
- Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting
- (2012) Timothy Rawson et al. JOURNAL OF INFECTION
- HIV Infection and Coronary Heart Disease: An Intersection of Epidemics
- (2012) Virginia A. Triant JOURNAL OF INFECTIOUS DISEASES
- Cardiovascular Risk Estimation in 2012: Lessons Learned and Applicability to the HIV Population
- (2012) R. B. D'Agostino JOURNAL OF INFECTIOUS DISEASES
- Low Bone Mineral Density, Regardless of HIV Status, in Men Who Have Sex With Men
- (2012) M. L. Grijsen et al. JOURNAL OF INFECTIOUS DISEASES
- Magnitude of Virologic Blips Is Associated With a Higher Risk for Virologic Rebound in HIV-Infected Individuals: A Recurrent Events Analysis
- (2012) J. Troy Grennan et al. JOURNAL OF INFECTIOUS DISEASES
- Sudden Cardiac Death in Patients With Human Immunodeficiency Virus Infection
- (2012) Zian H. Tseng et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks
- (2012) Paul E Sax et al. LANCET
- Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial
- (2012) Edwin DeJesus et al. LANCET
- Comparison of Bone and Renal Effects In HIV-infected Adults Switching to Abacavir or Tenofovir Based Therapy in a Randomized Trial
- (2012) Thomas A. Rasmussen et al. PLoS One
- Increased Risk of Virologic Rebound in Patients on Antiviral Therapy with a Detectable HIV Load
- (2012) Timothy J. Henrich et al. PLoS One
- Renal function and incidence of chronic kidney disease in HIV patients: A Danish cohort study
- (2012) Magnus G. Rasch et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings
- (2012) Thomas B. Campbell et al. PLOS MEDICINE
- Carotid Intima‐Media Thickness Progression in HIV‐Infected Adults Occurs Preferentially at the Carotid Bifurcation and Is Predicted by Inflammation
- (2012) Priscilla Y. Hsue et al. Journal of the American Heart Association
- Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons
- (2011) Andy I Choi et al. AIDS
- Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262)
- (2011) Babafemi Taiwo et al. AIDS
- CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy
- (2011) Ronald J. Ellis et al. AIDS
- Inappropriate claim of ‘failure of ritonavir-boosted lopinavir monotherapy in HIV’ in the Monotherapy Switzerland/Thailand (MOST) trial
- (2011) Nicholas I Paton et al. AIDS
- Abacavir use and cardiovascular disease events
- (2011) Mario Cruciani et al. AIDS
- Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir
- (2011) Neesha Rockwood et al. AIDS
- Relationship between renal dysfunction, nephrotoxicity and death among HIV adults on tenofovir
- (2011) Alana Brennan et al. AIDS
- Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients
- (2011) Pedro Cahn et al. AIDS
- Emerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremia
- (2011) Sébastien Gallien et al. AIDS
- Risk of cerebrovascular events in persons with and without HIV
- (2011) Line D. Rasmussen et al. AIDS
- Effects of vitamin D deficiency and combination antiretroviral therapy on bone in HIV-positive patients
- (2011) Kathryn Childs et al. AIDS
- Projected life expectancy of people with HIV according to timing of diagnosis
- (2011) Fumiyo Nakagawa et al. AIDS
- Incidence of low and high-energy fractures in persons with and without HIV infection
- (2011) Ann-Brit E. Hansen et al. AIDS
- Crossing the Divide: Transition Care Services for Young People with HIV—Their Views
- (2011) Hannah Bundock et al. AIDS PATIENT CARE AND STDS
- Predictors of Clinically Significant Drug-Drug Interactions Among Patients Treated with Nonnucleoside Reverse Transcriptase Inhibitor–, Protease Inhibitor–, and Raltegravir-Based Antiretroviral Regimens
- (2011) Nimish Patel et al. ANNALS OF PHARMACOTHERAPY
- Outcomes in the first year after initiation of first-line HAART among heterosexual men and women in the UK CHIC Study
- (2011) Tristan J Barber et al. ANTIVIRAL THERAPY
- Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial
- (2011) Vicente Soriano et al. ANTIVIRAL THERAPY
- Timing of HAART Initiation and Clinical Outcomes in Human Immunodeficiency Virus Type 1 Seroconverters
- (2011) Writing Committee for the CASCADE Collaboration* ARCHIVES OF INTERNAL MEDICINE
- Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare
- (2011) Christine Tapp et al. BMC INFECTIOUS DISEASES
- The Risk of Incident Coronary Heart Disease Among Veterans With and Without HIV and Hepatitis C
- (2011) Matthew S. Freiberg et al.
- Stable bone mineral density over 6 years in HIV-infected men treated with highly active antiretroviral therapy (HAART)
- (2011) Mark J Bolland et al. CLINICAL ENDOCRINOLOGY
- Peripheral and Central Fat Changes in Subjects Randomized to Abacavir-Lamivudine or Tenofovir-Emtricitabine With Atazanavir-Ritonavir or Efavirenz: ACTG Study A5224s
- (2011) G. A. McComsey et al. CLINICAL INFECTIOUS DISEASES
- Screening for Cognitive Impairment in Human Immunodeficiency Virus
- (2011) V. Valcour et al. CLINICAL INFECTIOUS DISEASES
- Abacavir Use and Risk of Acute Myocardial Infarction and Cerebrovascular Events in the Highly Active Antiretroviral Therapy Era
- (2011) R. J. Bedimo et al. CLINICAL INFECTIOUS DISEASES
- Time From Human Immunodeficiency Virus Seroconversion to Reaching CD4+ Cell Count Thresholds
- (2011) Sara Lodi et al. CLINICAL INFECTIOUS DISEASES
- No Risk of Myocardial Infarction Associated With Initial Antiretroviral Treatment Containing Abacavir: Short and Long-Term Results from ACTG A5001/ALLRT
- (2011) H. J. Ribaudo et al. CLINICAL INFECTIOUS DISEASES
- Timing of Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus (HIV)-Associated Tuberculous Meningitis
- (2011) M. E. Torok et al. CLINICAL INFECTIOUS DISEASES
- Contraceptive failure of etonogestrel implant in patients treated with antiretrovirals including efavirenz
- (2011) Nadia Leticee et al. CONTRACEPTION
- A decision tree to help determine the best timing and antiretroviral strategy in HIV-infected patients
- (2011) L. PIROTH et al. EPIDEMIOLOGY AND INFECTION
- Examination of Noninferiority, Safety, and Tolerability of Lopinavir/ritonavir and Raltegravir Compared with Lopinavir/ritonavir and Tenofovir/ Emtricitabine in Antiretroviral-Naïve Subjects: The PROGRESS Study, 48-Week Results
- (2011) Jacques Reynes et al. HIV CLINICAL TRIALS
- Reduced Emergence of the M184V/I Resistance Mutation When Antiretroviral-Naïve Subjects Use Emtricitabine Versus Lamivudine in Regimens Composed of Two NRTIs Plus the NNRTI Efavirenz
- (2011) Damian J. McColl et al. HIV CLINICAL TRIALS
- British HIV Association guidelines for the treatment of TB/HIV coinfection 2011
- (2011) AL Pozniak et al. HIV MEDICINE
- British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011
- (2011) D Asboe et al. HIV MEDICINE
- Impact of earlier HAART initiation on the immune status and clinical course of treated patients on the basis of cohort data of the German Competence Network for HIV/AIDS
- (2011) A. Plettenberg et al. INFECTION
- Use of Zidovudine-Sparing HAART in Pregnant HIV-Infected Women in Europe: 2000–2009
- (2011) Shema Tariq et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Association Between HIV Infection, Antiretroviral Therapy, and Risk of Acute Myocardial Infarction: A Cohort and Nested Case–Control Study Using Québecʼs Public Health Insurance Database
- (2011) Madeleine Durand et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Depression and HIV/AIDS Treatment Nonadherence: A Review and Meta-analysis
- (2011) Jeffrey S Gonzalez et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Genotypic and Phenotypic Characterization of HIV-1 Isolates Obtained From Patients on Rilpivirine Therapy Experiencing Virologic Failure in the Phase 3 ECHO and THRIVE Studies
- (2011) Laurence Rimsky et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment Failure
- (2011) Jonathan Z. Li JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ageing with HIV: medication use and risk for potential drug-drug interactions
- (2011) C. Marzolini et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Lopinavir/ritonavir single agent therapy as a universal combination antiretroviral therapy stopping strategy: results from the STOP 1 and STOP 2 studies
- (2011) S. Taylor et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir
- (2011) T. Bommenel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study
- (2011) Mattia C. F. Prosperi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Plasma concentrations of efavirenz are associated with body weight in HIV-positive individuals
- (2011) Julia Poeta et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial
- (2011) G. Fatkenheuer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Protease inhibitor monotherapy and the CNS: peace of mind?
- (2011) I. Perez-Valero et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Higher Rates of Bone Loss in Postmenopausal HIV-Infected Women: A Longitudinal Study
- (2011) Michael T. Yin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Abacavir/Lamivudine Versus Tenofovir DF/Emtricitabine as Part of Combination Regimens for Initial Treatment of HIV: Final Results
- (2011) Paul E. Sax et al. JOURNAL OF INFECTIOUS DISEASES
- Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202
- (2011) Grace A. McComsey et al. JOURNAL OF INFECTIOUS DISEASES
- Antiretroviral Drug Resistance in HIV-1–Infected Patients Experiencing Persistent Low-Level Viremia During First-Line Therapy
- (2011) Babafemi Taiwo et al. JOURNAL OF INFECTIOUS DISEASES
- Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy
- (2011) Frédéric-Antoine Dauchy et al. KIDNEY INTERNATIONAL
- Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial
- (2011) Calvin J Cohen et al. LANCET
- Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial
- (2011) Jean-Michel Molina et al. LANCET
- The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study
- (2011) Kimberly A Powers et al. LANCET
- Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial
- (2011) Joseph J Eron et al. LANCET INFECTIOUS DISEASES
- Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study
- (2011) Linda Wittkop et al. LANCET INFECTIOUS DISEASES
- Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study
- (2011) LANCET INFECTIOUS DISEASES
- Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study
- (2011) Jean-Michel Molina et al. LANCET INFECTIOUS DISEASES
- Use of antineoplastic agents in patients with cancer who have HIV/AIDS
- (2011) Michelle A Rudek et al. LANCET ONCOLOGY
- Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients
- (2011) N. Ciccarelli et al. NEUROLOGY
- Acute HIV-1 Infection
- (2011) Myron S. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Earlier versus Later Start of Antiretroviral Therapy in HIV-Infected Adults with Tuberculosis
- (2011) François-Xavier Blanc et al. NEW ENGLAND JOURNAL OF MEDICINE
- Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis
- (2011) Diane V. Havlir et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevention of HIV-1 Infection with Early Antiretroviral Therapy
- (2011) Myron S. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased Risk of Fragility Fractures among HIV Infected Compared to Uninfected Male Veterans
- (2011) Julie A. Womack et al. PLoS One
- Prevalence of Potential Drug-Drug Interactions Involving Antiretroviral Drugs in a Large Kenyan Cohort
- (2011) Gabriel Kigen et al. PLoS One
- Cost-Effectiveness of Early Treatment with First-Line NNRTI-Based HAART Regimens in the UK, 1996-2006
- (2011) Eduard J. Beck et al. PLoS One
- Effectiveness of Protease Inhibitor Monotherapy versus Combination Antiretroviral Maintenance Therapy: A Meta-Analysis
- (2011) Sandra Mathis et al. PLoS One
- Bone Mineral Density in HIV-Negative Men Participating in a Tenofovir Pre-Exposure Prophylaxis Randomized Clinical Trial in San Francisco
- (2011) Albert Y. Liu et al. PLoS One
- Pilot, Randomized Study Assessing Safety, Tolerability and Efficacy of Simplified LPV/r Maintenance Therapy in HIV Patients on the 1st PI-Based Regimen
- (2011) Pedro Cahn et al. PLoS One
- The Cost-Effectiveness of Early Access to HIV Services and Starting cART in the UK 1996–2008
- (2011) Eduard J. Beck et al. PLoS One
- Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters
- (2011) M Eugenia Socías et al. Journal of the International AIDS Society
- Women and Vulnerability to HAART Non-Adherence: A Literature Review of Treatment Adherence by Gender from 2000 to 2011
- (2011) Cathy M. Puskas et al. Current HIV/AIDS Reports
- Cost-Efficacy Analysis of the MONET Trial Using UK Antiretroviral Drug Prices
- (2011) Brian Gazzard et al. Applied Health Economics and Health Policy
- Safety of efavirenz in first-trimester of pregnancy: a systematic review and meta-analysis of outcomes from observational cohorts
- (2010) Nathan Ford et al. AIDS
- Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience
- (2010) Silvia Nozza et al. AIDS
- Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients
- (2010) Amit C Achhra et al. AIDS
- High prevalence of reduced bone mineral density in primary HIV-1-infected men
- (2010) Marlous L Grijsen et al. AIDS
- Emerging mutations at virological failure of HAART combinations containing tenofovir and lamivudine or emtricitabine
- (2010) Renato Maserati et al. AIDS
- High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study
- (2010) Anna Bonjoch et al. AIDS
- Determinants of HIV-1 transmission in men who have sex with men: a combined clinical, epidemiological and phylogenetic approach
- (2010) Martin Fisher et al. AIDS
- Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study
- (2010) Esteban Martinez et al. AIDS
- Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients
- (2010) Amanda Mocroft et al. AIDS
- Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population
- (2010) Sylvie Lang et al. AIDS
- A randomized crossover study to compare efavirenz and etravirine treatment
- (2010) Alain Nguyen et al. AIDS
- Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort
- (2010) Marlene Smurzynski et al. AIDS
- A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirine
- (2010) Laura Waters et al. AIDS
- Impact of Switching from Lopinavir/Ritonavir to Atazanavir/Ritonavir on Body Fat Redistribution in Virologically Suppressed HIV-Infected Adults
- (2010) Elena Ferrer et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- The antiretroviral potency of emtricitabine is approximately 3-fold higher compared to lamivudine in dual human immunodeficiency virus type 1 infection/competition experiments in vitro
- (2010) Daniel Drogan et al. ANTIVIRAL RESEARCH
- Prevalence of comedications and effect of potential drug–drug interactions in the Swiss HIV Cohort Study
- (2010) Catia Marzolini et al. ANTIVIRAL THERAPY
- HBV or HCV coinfections and risk of myocardial infarction in HIV-infected individuals: the D:A:D Cohort Study
- (2010) ANTIVIRAL THERAPY
- Impact of Individual Antiretroviral Drugs on the Risk of Myocardial Infarction in Human Immunodeficiency Virus–Infected PatientsA Case-Control Study Nested Within the French Hospital Database on HIV ANRS Cohort CO4Antiretroviral Drugs, Risk of MI, and HIV
- (2010) Sylvie Lang ARCHIVES OF INTERNAL MEDICINE
- Association Between Kidney Function and Albuminuria With Cardiovascular Events in HIV-Infected Persons
- (2010) Andy I. Choi et al. CIRCULATION
- Average Adherence to Boosted Protease Inhibitor Therapy, rather than the Pattern of Missed Doses, as a Predictor of HIV RNA Replication
- (2010) Jean‐Jacques Parienti et al. CLINICAL INFECTIOUS DISEASES
- Comparison of Changes in Bone Density and Turnover with Abacavir‐Lamivudine versus Tenofovir‐Emtricitabine in HIV‐Infected Adults: 48‐Week Results from the ASSERT Study
- (2010) Hans‐Jürgen Stellbrink et al. CLINICAL INFECTIOUS DISEASES
- Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy
- (2010) Ana Canestri et al. CLINICAL INFECTIOUS DISEASES
- Recognition of Risk for Clinically Significant Drug Interactions among HIV‐Infected Patients Receiving Antiretroviral Therapy
- (2010) John G. Evans‐Jones et al. CLINICAL INFECTIOUS DISEASES
- Efavirenz versus Boosted Atazanavir or Zidovudine and Abacavir in Antiretroviral Treatment–Naive, HIV‐Infected Subjects: Week 48 Data from the Altair Study
- (2010) Rebekah L. Puls et al. CLINICAL INFECTIOUS DISEASES
- Low CD4+T Cell Count Is a Risk Factor for Cardiovascular Disease Events in the HIV Outpatient Study
- (2010) Kenneth A. Lichtenstein et al. CLINICAL INFECTIOUS DISEASES
- Early versus Delayed Initiation of Antiretroviral Therapy for Concurrent HIV Infection and Cryptococcal Meningitis in Sub‐Saharan Africa
- (2010) Azure T. Makadzange et al. CLINICAL INFECTIOUS DISEASES
- Bone Disease in HIV Infection: A Practical Review and Recommendations for HIV Care Providers
- (2010) Grace A. McComsey et al. CLINICAL INFECTIOUS DISEASES
- Does Choice of Combination Antiretroviral Therapy (cART) Alter Changes in Cerebral Function Testing after 48 Weeks in Treatment‐Naive, HIV‐1–Infected Individuals Commencing cART? A Randomized, Controlled Study
- (2010) Alan Winston et al. CLINICAL INFECTIOUS DISEASES
- Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study
- (2010) Nina Friis-Møller et al. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION
- Monotherapy with Lopinavir/Ritonavir as Maintenance After HIV-1 Viral Suppression: Results of a 96-Week Randomized, Controlled, Open-Label, Pilot Trial (KalMo Study)
- (2010) Estevão P. Nunes et al. HIV CLINICAL TRIALS
- RETRACTED ARTICLE: Simplification From Protease Inhibitors to Once- or Twice-Daily Raltegravir: The ODIS Trial
- (2010) Eugenia Vispo et al. HIV CLINICAL TRIALS
- Neuropsychiatric Adverse Events With Ritonavir-Boosted Darunavir Monotherapy in HIV-Infected Individuals: A Randomised Prospective Study
- (2010) Alan Winston et al. HIV CLINICAL TRIALS
- Early Antiretroviral Therapy for Patients With Acute AIDS-Related Opportunistic Infections: A Cost-Effectiveness Analysis of ACTG A5164
- (2010) Paul E. Sax et al. HIV CLINICAL TRIALS
- Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USA
- (2010) HE Hsu et al. HIV MEDICINE
- Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial*
- (2010) AB Hansen et al. HIV MEDICINE
- When to Start Treatment? A Systematic Approach to the Comparison of Dynamic Regimes Using Observational Data
- (2010) Lauren E. Cain et al.
- Association of Immunologic and Virologic Factors With Myocardial Infarction Rates in a US Healthcare System
- (2010) Virginia A Triant et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- High Rates of Asymptomatic Neurocognitive Impairment in Vertically Acquired HIV-1–Infected Adolescents Surviving to Adulthood
- (2010) Yasotharan Paramesparan et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Incident Depression Symptoms Are Associated With Poorer HAART Adherence: A Longitudinal Analysis From the Nutrition for Healthy Living Study
- (2010) Deborah Kacanek et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Different Evolution of Genotypic Resistance Profiles to Emtricitabine Versus Lamivudine in Tenofovir-Containing Regimens
- (2010) Valentina Svicher et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Randomized Comparison of Renal Effects, Efficacy, and Safety With Once-Daily Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Administered With Efavirenz, in Antiretroviral-Naive, HIV-1–Infected Adults: 48-Week Results From the ASSERT Study
- (2010) Frank A Post et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe
- (2010) Amanda Mocroft et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Once-Daily Atazanavir/Ritonavir Compared With Twice-Daily Lopinavir/Ritonavir, Each in Combination With Tenofovir and Emtricitabine, for Management of Antiretroviral-Naive HIV-1-Infected Patients: 96-Week Efficacy and Safety Results of the CASTLE Study
- (2010) Jean-Michel Molina et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Raltegravir Versus Efavirenz Regimens in Treatment-Naive HIV-1–Infected Patients: 96-Week Efficacy, Durability, Subgroup, Safety, and Metabolic Analyses
- (2010) Jeffrey L Lennox et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Pregnancy Outcomes in Women Exposed to Efavirenz and Nevirapine: An Appraisal of the IeDEA West Africa and ANRS Databases, Abidjan, Côte dʼIvoire
- (2010) Didier K Ekouevi et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Suboptimal adherence to darunavir/ritonavir has minimal effect on efficacy compared with lopinavir/ritonavir in treatment-naive, HIV-infected patients: 96 week ARTEMIS data
- (2010) M. Nelson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Lopinavir/ritonavir monotherapy versus current treatment continuation for maintenance therapy of HIV-1 infection: the KALESOLO trial
- (2010) J.-L. Meynard et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparative gender analysis of the efficacy and safety of atazanavir/ritonavir and lopinavir/ritonavir at 96 weeks in the CASTLE study
- (2010) K. E. Squires et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities
- (2010) Leal C. Herlitz et al. KIDNEY INTERNATIONAL
- Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials
- (2010) Joseph J Eron et al. LANCET
- Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
- (2010) Deborah Donnell et al. LANCET
- Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons
- (2010) E. J. Wright et al. NEUROLOGY
- HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study
- (2010) R. K. Heaton et al. NEUROLOGY
- Outcomes of Kidney Transplantation in HIV-Infected Recipients
- (2010) Peter G. Stock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy
- (2010) Salim S. Abdool Karim et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Controlled, Trial of Short Cycle Intermittent Compared to Continuous Antiretroviral Therapy for the Treatment of HIV Infection in Uganda
- (2010) Steven J. Reynolds et al. PLoS One
- Risk Factor Analyses for Immune Reconstitution Inflammatory Syndrome in a Randomized Study of Early vs. Deferred ART during an Opportunistic Infection
- (2010) Philip M. Grant et al. PLoS One
- Rising Population Cost for Treating People Living with HIV in the UK, 1997-2013
- (2010) Sundhiya Mandalia et al. PLoS One
- Stress and Poverty Predictors of Treatment Adherence Among People With Low-Literacy Living With HIV/AIDS
- (2010) Seth C. Kalichman et al. PSYCHOSOMATIC MEDICINE
- Role of acute and early HIV infection in the sexual transmission of HIV
- (2010) William C Miller et al. Current Opinion in HIV and AIDS
- Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance
- (2009) Edward M Gardner et al. AIDS
- Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients
- (2009) Jean-François Delfraissy et al. AIDS
- Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV
- (2009) Federico Pulido et al. AIDS
- Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48
- (2009) Roberto Ortiz et al. AIDS
- High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets
- (2009) Hanneke MJ Nijland et al. AIDS
- Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease
- (2009) Robert C Kalayjian et al. AIDS
- Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study
- (2009) Carl Grunfeld et al. AIDS
- HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy
- (2009) Andy I Choi et al. AIDS
- Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance
- (2009) Christina M Marra et al. AIDS
- Antiretroviral therapy and congenital abnormalities in infants born to HIV-infected women in the UK and Ireland, 1990–2007
- (2009) Claire L Townsend et al. AIDS
- Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment
- (2009) Kimberly Y Smith et al. AIDS
- Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir
- (2009) Pablo Labarga et al. AIDS
- The impact of AIDS diagnoses on long-term neurocognitive and psychiatric outcomes of surviving adolescents with perinatally acquired HIV
- (2009) Sarah M Wood et al. AIDS
- Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials
- (2009) Christine Katlama et al. AIDS
- Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis
- (2009) Suzanna Attia et al. AIDS
- Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy
- (2009) Anouk M Kesselring et al. AIDS
- Continuous antiretroviral therapy decreases bone mineral density
- (2009) Birgit Grund et al. AIDS
- Antiretroviral medication adherence and the development of class-specific antiretroviral resistance
- (2009) Edward M Gardner et al. AIDS
- The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml
- (2009) Jose R Arribas et al. AIDS
- Young People in the United Kingdom and Ireland with Perinatally Acquired HIV: The Pediatric Legacy For Adult Services
- (2009) Caroline Foster et al. AIDS PATIENT CARE AND STDS
- Effect of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes, on the Pharmacokinetics of Raltegravir
- (2009) L. A. Wenning et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Severe toxicity related to a pharmacokinetic interaction between docetaxel and ritonavir in HIV-infected patients
- (2009) Olivier Mir et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Do Benefits of Earlier Antiretroviral Treatment Initiation Outweigh Harms for Individuals at Risk for Poor Adherence?
- (2009) R. Scott Braithwaite et al. CLINICAL INFECTIOUS DISEASES
- Treatment Responses in Antiretroviral Treatment–Naive Premenopausal and Postmenopausal HIV‐1–Infected Women: An Analysis from AIDS Clinical Trials Group Studies
- (2009) Kristine B. Patterson et al. CLINICAL INFECTIOUS DISEASES
- Simplification of Antiretroviral Therapy with Tenofovir‐Emtricitabine or Abacavir‐Lamivudine: A Randomized, 96‐Week Trial
- (2009) Allison Martin et al. CLINICAL INFECTIOUS DISEASES
- Rifamycin‐ResistantMycobacterium tuberculosisin the Highly Active Antiretroviral Therapy Era: A Report of 3 Relapses with Acquired Rifampin Resistance following Alternate‐Day Rifabutin and Boosted Protease Inhibitor Therapy
- (2009) Elizabeth R. Jenny‐Avital et al. CLINICAL INFECTIOUS DISEASES
- High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment‐Experienced Patients Infected with Multidrug‐Resistant HIV: Results of the ANRS 139 TRIO Trial
- (2009) Y. Yazdanpanah et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetics and Pharmacodynamics of GS-9350: A Novel Pharmacokinetic Enhancer Without Anti-HIV Activity
- (2009) A A Mathias et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Reply:
- (2009) Teresa Ignacio CORNEA
- Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit
- (2009) Julio Croda et al. CRITICAL CARE MEDICINE
- Targeted therapies to treat non-AIDS-defining cancers in patients with HIV on HAART therapy: treatment considerations and research outlook
- (2009) John F Deeken et al. CURRENT OPINION IN ONCOLOGY
- The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naïve HIV-1 infected patients
- (2009) Filip Josephson et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Causes and Consequences of Incomplete HIV RNA Suppression in Clinical Trials
- (2009) Anton Pozniak et al. HIV CLINICAL TRIALS
- Low-Level Viremia in HIV-1 Infection: Consequences and Implications for Switching to a New Regimen
- (2009) Calvin Cohen HIV CLINICAL TRIALS
- Correction of facial lipoatrophy using autologous fat transplants in HIV-infected adolescents
- (2009) C Dollfus et al. HIV MEDICINE
- Spectrum of chronic kidney disease in HIV-infected patients
- (2009) LJ Campbell et al. HIV MEDICINE
- Tenofovir-associated renal and bone toxicity
- (2009) CLN Woodward et al. HIV MEDICINE
- Abacavir and risk of myocardial infarction in HIV-infected patients on highly active antiretroviral therapy: a population-based nationwide cohort study
- (2009) N Obel et al. HIV MEDICINE
- Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppression
- (2009) V Cambiano et al. HIV MEDICINE
- Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive Agents
- (2009) Ajay K. Gupta et al. HYPERTENSION
- Prevalence and Predictors of Deterioration of a Trustful Patient-Provider Relationship Among HIV-Infected Persons Treated With Antiretroviral Therapy
- (2009) Marie Préau et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Efficacy and Safety of Switching From Boosted Lopinavir to Boosted Atazanavir in Patients With Virological Suppression Receiving a LPV/r-Containing HAART: The ATAZIP Study
- (2009) Josep Mallolas et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Gemini: A Noninferiority Study of Saquinavir/Ritonavir Versus Lopinavir/Ritonavir as Initial HIV-1 Therapy in Adults
- (2009) Sharon Walmsley et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Risk of Myocardial Infarction and Abacavir Therapy: No Increased Risk Across 52 GlaxoSmithKline-Sponsored Clinical Trials in Adult Subjects
- (2009) Cindy H Brothers et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Increased Reporting of Detectable Plasma HIV-1 RNA Levels at the Critical Threshold of 50 Copies per Milliliter With the Taqman Assay in Comparison to the Amplicor Assay
- (2009) Viviane Lima et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Lopinavir-Ritonavir Monotherapy Versus Lopinavir-Ritonavir and 2 Nucleosides for Maintenance Therapy of HIV: 96-Week Analysis
- (2009) Jose R Arribas et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Hepatotoxicity and Gastrointestinal Intolerance When Healthy Volunteers Taking Rifampin Add Twice-Daily Atazanavir and Ritonavir
- (2009) David W Haas et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Changes in Cognition During Antiretroviral Therapy: Comparison of 2 Different Ranking Systems to Measure Antiretroviral Drug Efficacy on HIV-Associated Neurocognitive Disorders
- (2009) Valerio Tozzi et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Sustained Antiretroviral Effect of Raltegravir After 96 Weeks of Combination Therapy in Treatment-Naive Patients With HIV-1 Infection
- (2009) Martin Markowitz et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Gender Differences in Discontinuation of Antiretroviral Treatment Regimens
- (2009) Mirjam-Colette Kempf et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Alcohol Use and Antiretroviral Adherence: Review and Meta-Analysis
- (2009) Christian S Hendershot et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Antiretroviral Therapy Adherence, Virologic and Immunologic Outcomes in Adolescents Compared With Adults in Southern Africa
- (2009) Jean B Nachega et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort
- (2009) L. Wittkop et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study
- (2009) R. Landman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study
- (2009) Signe Westring Worm et al. JOURNAL OF INFECTIOUS DISEASES
- Lithium therapy for human immunodeficiency virus type 1–associated neurocognitive impairment
- (2009) Giovanni Schifitto et al. JOURNAL OF NEUROVIROLOGY
- Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
- (2009) Jeffrey L Lennox et al. LANCET
- Selegiline and oxidative stress in HIV-associated cognitive impairment
- (2009) G. Schifitto et al. NEUROLOGY
- Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy
- (2009) L. A. Cysique et al. NEUROLOGY
- Abacavir–Lamivudine versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy
- (2009) Paul E. Sax et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
- (2009) Mari M. Kitahata et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Antiretroviral Therapy Reduces AIDS Progression/Death in Individuals with Acute Opportunistic Infections: A Multicenter Randomized Strategy Trial
- (2009) Andrew R. Zolopa et al. PLoS One
- Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen
- (2008) Zoe Fox et al. AIDS
- The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients
- (2008) Joel E Gallant et al. AIDS
- Efavirenz-induced osteomalacia
- (2008) Christian Herzmann et al. AIDS
- Relationship between Adherence Level, Type of the Antiretroviral Regimen, and Plasma HIV Type 1 RNA Viral Load: A Prospective Cohort Study
- (2008) M. Martin et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Minimal Effects of Ritonavir and Efavirenz on the Pharmacokinetics of Raltegravir
- (2008) M. Iwamoto et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous System
- (2008) Scott Letendre ARCHIVES OF NEUROLOGY
- Discontinuation of Nevirapine Because of Hypersensitivity Reactions in Patients with Prior Treatment Experience, Compared with Treatment-Naive Patients: The ATHENA Cohort Study
- (2008) F. W. N. M. Wit et al. CLINICAL INFECTIOUS DISEASES
- Predictors of Renal Outcome in HIV‐Associated Nephropathy
- (2008) Frank A. Post et al. CLINICAL INFECTIOUS DISEASES
- Severe Renal Dysfunction and Risk Factors Associated with Renal Impairment in HIV‐Infected Adults in Africa Initiating Antiretroviral Therapy
- (2008) Andrew Reid et al. CLINICAL INFECTIOUS DISEASES
- Switching from suppressive protease inhibitor-based regimens to nevirapine-based regimens: a meta-analysis of randomized controlled trials
- (2008) J Ena et al. HIV MEDICINE
- British HIV Association, BASHH and FSRH guidelines for the management of the sexual and reproductive health of people living with HIV infection 2008
- (2008) A Fakoya et al. HIV MEDICINE
- British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008
- (2008) BG Gazzard et al. HIV MEDICINE
- Evolution and Predictors of Change in Total Bone Mineral Density Over Time in HIV-Infected Men and Women in the Nutrition for Healthy Living Study
- (2008) Denise L Jacobson et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Outcomes of Nevirapine- and Efavirenz-Based Antiretroviral Therapy When Coadministered With Rifampicin-Based Antitubercular Therapy
- (2008) Andrew Boulle JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Highly Active Antiretroviral Therapy and Survival in HIV-Infected Injection Drug Users
- (2008) Evan Wood JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome
- (2008) P. Garcia-Gasco et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Fracture Prevalence among Human Immunodeficiency Virus (HIV)-InfectedVersusNon-HIV-Infected Patients in a Large U.S. Healthcare System
- (2008) Virginia A. Triant et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Durability and Outcome of Initial Antiretroviral Treatments Received during 2000–2005 by Patients in the Swiss HIV Cohort Study
- (2008) Thi Tuyet Nhung Vo et al. JOURNAL OF INFECTIOUS DISEASES
- Preexisting Resistance to Nonnucleoside Reverse‐Transcriptase Inhibitors Predicts Virologic Failure of an Efavirenz‐Based Regimen in Treatment‐Naive HIV‐1–Infected Subjects
- (2008) Daniel R. Kuritzkes et al. JOURNAL OF INFECTIOUS DISEASES
- HIV-1 Transmission, by Stage of Infection
- (2008) T. Déirdre Hollingsworth et al. JOURNAL OF INFECTIOUS DISEASES
- Brief Report: Language Ability and School Functioning of Youth Perinatally Infected With HIV
- (2008) Elizabeth Brackis-Cott et al. Journal of Pediatric Health Care
- Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study
- (2008) Jean-Michel Molina et al. LANCET
- Class-Sparing Regimens for Initial Treatment of HIV-1 Infection
- (2008) Sharon A. Riddler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Maraviroc for Previously Treated Patients with R5 HIV-1 Infection
- (2008) Roy M. Gulick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection
- (2008) Roy T. Steigbigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Going from evidence to recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
- A Paradigm Shift to Prevent HIV Drug Resistance
- (2008) David R Bangsberg PLOS MEDICINE
- Strategies for promoting adherence to antiretroviral therapy: A review of the literature
- (2008) Jane M. Simoni et al. Current Infectious Disease Reports
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation